BlackRock Amends PetMed Express Stake (SC 13G/A)
Ticker: PETS · Form: SC 13G/A · Filed: Jan 25, 2024 · CIK: 1040130
| Field | Detail |
|---|---|
| Company | Petmed Express Inc (PETS) |
| Form Type | SC 13G/A |
| Filed Date | Jan 25, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock updated its passive stake in PetMed Express; watch for market reaction.**
AI Summary
BlackRock, Inc. filed an amended SC 13G/A on January 25, 2024, indicating a change in its ownership stake in PetMed Express Inc. as of December 31, 2023. This filing, Amendment No. 4, updates previous disclosures about BlackRock's passive investment in the pet medication retailer. This matters to investors because BlackRock is a major institutional investor, and changes in its holdings can signal shifts in its confidence or strategy regarding PetMed Express stock.
Why It Matters
This filing shows BlackRock's updated position in PetMed Express, which can influence market perception and potentially stock price due to the size and influence of BlackRock.
Risk Assessment
Risk Level: low — This is a routine update from a passive institutional investor and does not indicate any immediate, significant risk to the company.
Analyst Insight
An investor should view this as a standard disclosure from a large institutional investor. It doesn't signal an immediate buy or sell, but rather confirms BlackRock's continued, albeit potentially adjusted, passive interest in PetMed Express. Further analysis of the specific share count change (not provided in this excerpt) would be needed for a more informed decision.
Key Numbers
- 716382106 — CUSIP Number (identifies the Common Stock of PetMed Express Inc.)
- 0001364742 — BlackRock's CIK (Central Index Key for BlackRock Inc.)
- 0001040130 — PetMed Express's CIK (Central Index Key for PetMed Express Inc.)
Key Players & Entities
- BlackRock, Inc. (company) — the reporting person filing the SC 13G/A
- PetMed Express Inc. (company) — the subject company in which BlackRock holds shares
- December 31, 2023 (date) — the date of the event requiring the filing
- January 25, 2024 (date) — the filing date of the SC 13G/A
- Amendment No: 4 (number) — the specific amendment number of the filing
Forward-Looking Statements
- BlackRock will continue to hold a significant, passive stake in PetMed Express Inc. (BlackRock, Inc.) — high confidence, target: Q2 2024
- The market will interpret this as a routine update rather than a major strategic shift. (PetMed Express Inc. stock) — high confidence, target: February 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, specifically Amendment No. 4, as stated in the filing.
Who is the reporting person in this filing?
The reporting person is BlackRock, Inc., as explicitly stated under '(1)Names of reporting persons. BlackRock, Inc.' in the filing.
What is the name of the issuer whose securities are being reported?
The name of the issuer is PETMED EXPRESS INC, as indicated under '(Name of Issuer)' in the filing.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the Common Stock of PetMed Express Inc. is 716382106, as listed in the filing.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified in the document.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 25, 2024 regarding PETMED EXPRESS INC (PETS).